332 related articles for article (PubMed ID: 32205569)
1. Preclinical rheumatoid arthritis and rheumatoid arthritis prevention.
Greenblatt HK; Kim HA; Bettner LF; Deane KD
Curr Opin Rheumatol; 2020 May; 32(3):289-296. PubMed ID: 32205569
[TBL] [Abstract][Full Text] [Related]
2. Preclinical Rheumatoid Arthritis and Rheumatoid Arthritis Prevention.
Deane KD
Curr Rheumatol Rep; 2018 Jun; 20(8):50. PubMed ID: 29946747
[TBL] [Abstract][Full Text] [Related]
3. Pre-RA: Can early diagnosis lead to prevention?
Haville S; Deane KD
Best Pract Res Clin Rheumatol; 2022 Mar; 36(1):101737. PubMed ID: 34991984
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to citrullinated protein antigens (ACPAs): clinical and pathophysiologic significance.
Demoruelle MK; Deane K
Curr Rheumatol Rep; 2011 Oct; 13(5):421-30. PubMed ID: 21713412
[TBL] [Abstract][Full Text] [Related]
5. Preclinical rheumatoid arthritis (autoantibodies): an updated review.
Deane KD
Curr Rheumatol Rep; 2014 May; 16(5):419. PubMed ID: 24643396
[TBL] [Abstract][Full Text] [Related]
6. Rheumatoid Arthritis Pathogenesis, Prediction, and Prevention: An Emerging Paradigm Shift.
Deane KD; Holers VM
Arthritis Rheumatol; 2021 Feb; 73(2):181-193. PubMed ID: 32602263
[TBL] [Abstract][Full Text] [Related]
7. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
8. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis.
Sokolove J; Bromberg R; Deane KD; Lahey LJ; Derber LA; Chandra PE; Edison JD; Gilliland WR; Tibshirani RJ; Norris JM; Holers VM; Robinson WH
PLoS One; 2012; 7(5):e35296. PubMed ID: 22662108
[TBL] [Abstract][Full Text] [Related]
9. Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy Controls.
Koppejan H; Trouw LA; Sokolove J; Lahey LJ; Huizinga TJ; Smolik IA; Robinson DB; El-Gabalawy HS; Toes RE; Hitchon CA
Arthritis Rheumatol; 2016 Sep; 68(9):2090-8. PubMed ID: 26946484
[TBL] [Abstract][Full Text] [Related]
10. A Comprehensive Evaluation of the Relationship Between Different IgG and IgA Anti-Modified Protein Autoantibodies in Rheumatoid Arthritis.
Grönwall C; Liljefors L; Bang H; Hensvold AH; Hansson M; Mathsson-Alm L; Israelsson L; Joshua V; Svärd A; Stålesen R; Titcombe PJ; Steen J; Piccoli L; Sherina N; Clavel C; Svenungsson E; Gunnarsson I; Saevarsdottir S; Kastbom A; Serre G; Alfredsson L; Malmström V; Rönnelid J; Catrina AI; Lundberg K; Klareskog L
Front Immunol; 2021; 12():627986. PubMed ID: 34093522
[TBL] [Abstract][Full Text] [Related]
11. Clinical and pathophysiologic relevance of autoantibodies in rheumatoid arthritis.
de Brito Rocha S; Baldo DC; Andrade LEC
Adv Rheumatol; 2019 Jan; 59(1):2. PubMed ID: 30657101
[TBL] [Abstract][Full Text] [Related]
12. From Rheumatoid Factor to Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies for Diagnosis and Prognosis Prediction in Patients with Rheumatoid Arthritis.
Wu CY; Yang HY; Luo SF; Lai JH
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445768
[TBL] [Abstract][Full Text] [Related]
13. The role of ACPAs in at-risk individuals: Early targeting of the bone and joints.
Schett G
Best Pract Res Clin Rheumatol; 2017 Feb; 31(1):53-58. PubMed ID: 29221598
[TBL] [Abstract][Full Text] [Related]
14. Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis.
Gan RW; Trouw LA; Shi J; Toes RE; Huizinga TW; Demoruelle MK; Kolfenbach JR; Zerbe GO; Deane KD; Edison JD; Gilliland WR; Norris JM; Holers VM
J Rheumatol; 2015 Apr; 42(4):572-9. PubMed ID: 25593232
[TBL] [Abstract][Full Text] [Related]
15. Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis.
de Hair MJ; van de Sande MG; Ramwadhdoebe TH; Hansson M; Landewé R; van der Leij C; Maas M; Serre G; van Schaardenburg D; Klareskog L; Gerlag DM; van Baarsen LG; Tak PP
Arthritis Rheumatol; 2014 Mar; 66(3):513-22. PubMed ID: 24574210
[TBL] [Abstract][Full Text] [Related]
16. Anti-citrullinated protein antibodies and their clinical utility in rheumatoid arthritis.
Farid SSh; Azizi G; Mirshafiey A
Int J Rheum Dis; 2013 Aug; 16(4):379-86. PubMed ID: 23992255
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis.
Chang PY; Yang CT; Cheng CH; Yu KH
Int J Rheum Dis; 2016 Sep; 19(9):880-6. PubMed ID: 25940989
[TBL] [Abstract][Full Text] [Related]
18. Triple Positivity for Anti-Citrullinated Protein Autoantibodies, Rheumatoid Factor, and Anti-Carbamylated Protein Antibodies Conferring High Specificity for Rheumatoid Arthritis: Implications for Very Early Identification of At-Risk Individuals.
Verheul MK; Böhringer S; van Delft MAM; Jones JD; Rigby WFC; Gan RW; Holers VM; Edison JD; Deane KD; Janssen KMJ; Westra J; Brink M; Rantapää-Dahlqvist S; Huizinga TWJ; van der Helm-van Mil AHM; van der Woude D; Toes REM; Trouw LA
Arthritis Rheumatol; 2018 Nov; 70(11):1721-1731. PubMed ID: 29781231
[TBL] [Abstract][Full Text] [Related]
19. Relatives without rheumatoid arthritis show reactivity to anti-citrullinated protein/peptide antibodies that are associated with arthritis-related traits: studies of the etiology of rheumatoid arthritis.
Young KA; Deane KD; Derber LA; Hughes-Austin JM; Wagner CA; Sokolove J; Weisman MH; Buckner JH; Mikuls TR; O'Dell JR; Keating RM; Gregersen PK; Robinson WH; Holers VM; Norris JM
Arthritis Rheum; 2013 Aug; 65(8):1995-2004. PubMed ID: 23754702
[TBL] [Abstract][Full Text] [Related]
20. The pre-clinical phase of rheumatoid arthritis: From risk factors to prevention of arthritis.
Petrovská N; Prajzlerová K; Vencovský J; Šenolt L; Filková M
Autoimmun Rev; 2021 May; 20(5):102797. PubMed ID: 33746022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
